# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4144686 | A | Cytotoxicity against PBMC (unknown origin) assessed as cell viability at 20 uM after 24 hrs by trypan blue exclusion assay relative to control | Not specified | 1 | cell-based format | Scientific Literature | ||
2. | ALA4144687 | A | Cytotoxicity against PBMC (unknown origin) assessed as reduction in cell viability at 1 to 20 uM after 24 hrs by trypan blue exclusion assay | Not specified | 1 | cell-based format | Scientific Literature | ||
3. | ALA4263124 | A | Cytotoxicity against PBMC (unknown origin) assessed as reduction in cell viability up to 500 uM by CCK8 assay | Not specified | 1 | cell-based format | Scientific Literature | ||
4. | ALA4321235 | A | Cytotoxicity against PBMC (unknown origin) assessed as cell death | Not specified | 1 | cell-based format | Scientific Literature | ||
5. | ALA4363794 | F | Anti-atherosclerotic activity in C57BL/6 mouse PBMC assessed as inhibition of ox-LDL induced lipid accumulation at 10 uM incubated for 48 hrs by ORO staining based microscopic analysis | Mus musculus | 2 | cell-based format | Scientific Literature | ||
6. | ALA4363800 | A | Effect on LXR mRNA expression in C57BL/6 mouse PBMC at 10 uM incubated for 48 hrs by qPCR analysis | Mus musculus | 1 | cell-based format | Scientific Literature | ||
7. | ALA4419323 | F | Inhibition of LPS-induced TNFalpha production in PBMC (unknown origin) incubated for 16 hrs by ELISA | Not specified | 21 | cell-based format | Patent Bioactivity Data | ||
8. | ALA4624169 | A | Cytotoxicity against PBMC (unknown origin) after 48 hrs by MTT assay | Not specified | 1 | cell-based format | Scientific Literature | ||
9. | ALA4628553 | A | Cytotoxicity against PBMC (unknown origin) | Not specified | 10 | cell-based format | Scientific Literature |